View the DAPAZIN 10 MG registration information details.
Back to drug list
ItemsDrug Registration information
ID377
No377
Brand NameDAPAZIN 10 MG
IngredientsDAPAGLIFLOZIN INN 10 MG
Dosage FormTABLET
Primary PackagingALU-ALU BLISTER
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 1 X 14'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsTO REDUCE THE RISK OF SUSTAINED EGFR DECLINE, END STAGE KIDNEY DISEASE, CARDIOVASCULAR DEATH AND HOSPITALIZATION FOR HEART FAILURE IN ADULTS WITH CHRONIC KIDNEY DISEASE AT RISK OF PROGRESSION, AS AN ADJUNCT TO DIET AND EXCERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionLIGHT ORANGE COLOR DIAMOND SHAPED FILM COATED TABLET HAVING ENGRAVED CONCORD ON ONE SIDE AND BREAK LINE ON OTHER SIDE
Note
License OwnerCITI TRADE IMPORT-EXPORT SOLE CO.,LTD
ManufacturerCONCORD PHARMACEUTICAL LTD
CountryBANGLADESH
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No02 I 5882/25
FDD Registration Date45712
Expiry Date47537
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA